Back
Rate this talk
Your peers have not rated this talk yet.
12-minute watch | Talk 3 of 7

EHA: Tracing the steps to CAR T and beyond

Treatment selection in 2L DLBCL

Dr Sridhar Chaganti
SYMPOSIUM
EHA

Dr Sridhar Chaganti
The University Hospitals Birmingham, Birmingham, UK

Dr Sridhar Chaganti, The University Hospitals Birmingham, Birmingham, UK, provides an overview of treatment options available and how to select them for R/R DLBCL

Read more

Talks in this series

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
12-minute watch | Talk 3 of 7
Treatment selection in 2L DLBCL
Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
12-minute watch

Treatment selection in 2L DLBCL

Dr Sridhar Chaganti

Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
12-minute watch | Talk 3 of 7
Treatment selection in 2L DLBCL
Dr Sridhar Chaganti
Dr Sridhar Chaganti presents at EHA (Tracing the steps to CAR T and beyond)
12-minute watch

Treatment selection in 2L DLBCL

Dr Sridhar Chaganti

Interested in this topic?

Find more like this

  This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In the United Kingdom, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.